首页 > 最新文献

Non-coding RNA Research最新文献

英文 中文
SNHG5 enhances colorectal cancer metastasis through RNA–protein interaction with GNB2 and activation of canonical Wnt signaling SNHG5通过rna -蛋白与GNB2的相互作用和典型Wnt信号的激活促进结直肠癌转移
IF 4.7 3区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2026-01-02 DOI: 10.1016/j.ncrna.2025.12.002
Xinyi Chen , Mu Yang , Xiaoxiao Luo, Xianglin Yuan

Background and purpose

Colorectal cancer (CRC) is one of the most prevalent and lethal malignancies worldwide, with distant metastasis—particularly to the liver—representing the primary cause of poor prognosis. Long non-coding RNAs (lncRNAs) have emerged as critical regulators of CRC progression, yet the mechanisms by which they modulate G protein signaling during hepatic metastasis remain unclear. This study aimed to determine the role of the lncRNA SNHG5 in CRC liver metastasis and to explore whether G protein–related mechanisms are involved in this process.

Methods

We established murine MC38 CRC sublines with distinct metastatic capacities (F0 and F3) and performed RNA sequencing to identify key lncRNAs. Biotin-labeled RNA pull-down coupled with mass spectrometry was used to identify SNHG5-interacting proteins. The SNHG5–GNB2 interaction was validated using RIP, RNA-FISH, and Western blot analyses. Functional rescue assays, in vivo liver metastasis models, and Wnt pathway activity measurements were conducted to delineate downstream effects. Public transcriptomic datasets from GEO and TCGA were used to assess the expression patterns and prognostic relevance of SNHG5 and GNB2 in CRC and metastatic lesions.

Results

SNHG5 was significantly upregulated in the highly metastatic F3 subline and predominantly localized in the cytoplasm. Pull-down and proteomic analysis identified GNB2, a classical G protein β-subunit, as a direct binding partner of SNHG5. Functionally, SNHG5 promoted cell proliferation, migration, epithelial–mesenchymal transition (EMT), and suppressed apoptosis, while GNB2 overexpression partially rescued the tumor-suppressive phenotypes induced by SNHG5 silencing. Mechanistically, the SNHG5–GNB2 axis enhanced Wnt/β-catenin signaling via increased p-GSK3β and β-catenin levels, thereby driving EMT. Transcriptomic analyses further revealed that GNB2 is upregulated in CRC and liver metastases and is associated with poor prognosis. Multi-omics data suggested additional roles for this axis in immune evasion, metabolic reprogramming, and remodeling of the metastatic microenvironment.

Conclusion

This study provides the first evidence that SNHG5 promotes CRC liver metastasis through direct interaction with GNB2 and subsequent activation of the Wnt/β-catenin pathway. The SNHG5–GNB2 axis orchestrates a multilayered regulatory network that integrates EMT induction, immune suppression, and metabolic adaptation, highlighting its potential as a mechanistic driver and therapeutic target in metastatic CRC.
背景和目的结直肠癌(CRC)是世界范围内最常见和最致命的恶性肿瘤之一,其远处转移(尤其是肝脏)是导致预后不良的主要原因。长链非编码rna (lncRNAs)已成为结直肠癌进展的关键调节因子,但它们在肝转移过程中调节G蛋白信号的机制尚不清楚。本研究旨在确定lncRNA SNHG5在结直肠癌肝转移中的作用,并探讨G蛋白相关机制是否参与这一过程。方法建立具有不同转移能力(F0和F3)的小鼠MC38 CRC亚群,并进行RNA测序以鉴定关键lncrna。生物素标记RNA下拉联用质谱法鉴定snhg5相互作用蛋白。SNHG5-GNB2相互作用通过RIP、RNA-FISH和Western blot分析验证。通过功能恢复实验、体内肝转移模型和Wnt通路活性测量来描述下游效应。来自GEO和TCGA的公共转录组数据用于评估SNHG5和GNB2在结直肠癌和转移性病变中的表达模式和预后相关性。结果snhg5在高转移性的F3亚系中表达显著上调,且主要定位于细胞质中。Pull-down和蛋白质组学分析发现,GNB2是一个经典的G蛋白β亚基,是SNHG5的直接结合伙伴。功能上,SNHG5促进细胞增殖、迁移、上皮-间质转化(epithelial-mesenchymal transition, EMT),抑制细胞凋亡,而GNB2过表达部分恢复了SNHG5沉默诱导的肿瘤抑制表型。机制上,SNHG5-GNB2轴通过增加p-GSK3β和β-catenin水平增强Wnt/β-catenin信号传导,从而驱动EMT。转录组学分析进一步显示,GNB2在结直肠癌和肝转移中表达上调,并与预后不良相关。多组学数据表明,该轴在免疫逃避、代谢重编程和转移性微环境重塑中具有其他作用。结论本研究首次证实SNHG5通过与GNB2直接相互作用并随后激活Wnt/β-catenin通路促进结直肠癌肝转移。SNHG5-GNB2轴协调了一个多层调控网络,整合了EMT诱导、免疫抑制和代谢适应,突出了其作为转移性结直肠癌的机制驱动和治疗靶点的潜力。
{"title":"SNHG5 enhances colorectal cancer metastasis through RNA–protein interaction with GNB2 and activation of canonical Wnt signaling","authors":"Xinyi Chen ,&nbsp;Mu Yang ,&nbsp;Xiaoxiao Luo,&nbsp;Xianglin Yuan","doi":"10.1016/j.ncrna.2025.12.002","DOIUrl":"10.1016/j.ncrna.2025.12.002","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Colorectal cancer (CRC) is one of the most prevalent and lethal malignancies worldwide, with distant metastasis—particularly to the liver—representing the primary cause of poor prognosis. Long non-coding RNAs (lncRNAs) have emerged as critical regulators of CRC progression, yet the mechanisms by which they modulate G protein signaling during hepatic metastasis remain unclear. This study aimed to determine the role of the lncRNA SNHG5 in CRC liver metastasis and to explore whether G protein–related mechanisms are involved in this process.</div></div><div><h3>Methods</h3><div>We established murine MC38 CRC sublines with distinct metastatic capacities (F0 and F3) and performed RNA sequencing to identify key lncRNAs. Biotin-labeled RNA pull-down coupled with mass spectrometry was used to identify SNHG5-interacting proteins. The SNHG5–GNB2 interaction was validated using RIP, RNA-FISH, and Western blot analyses. Functional rescue assays, in vivo liver metastasis models, and Wnt pathway activity measurements were conducted to delineate downstream effects. Public transcriptomic datasets from GEO and TCGA were used to assess the expression patterns and prognostic relevance of SNHG5 and GNB2 in CRC and metastatic lesions.</div></div><div><h3>Results</h3><div>SNHG5 was significantly upregulated in the highly metastatic F3 subline and predominantly localized in the cytoplasm. Pull-down and proteomic analysis identified GNB2, a classical G protein β-subunit, as a direct binding partner of SNHG5. Functionally, SNHG5 promoted cell proliferation, migration, epithelial–mesenchymal transition (EMT), and suppressed apoptosis, while GNB2 overexpression partially rescued the tumor-suppressive phenotypes induced by SNHG5 silencing. Mechanistically, the SNHG5–GNB2 axis enhanced Wnt/β-catenin signaling via increased p-GSK3β and β-catenin levels, thereby driving EMT. Transcriptomic analyses further revealed that GNB2 is upregulated in CRC and liver metastases and is associated with poor prognosis. Multi-omics data suggested additional roles for this axis in immune evasion, metabolic reprogramming, and remodeling of the metastatic microenvironment.</div></div><div><h3>Conclusion</h3><div>This study provides the first evidence that SNHG5 promotes CRC liver metastasis through direct interaction with GNB2 and subsequent activation of the Wnt/β-catenin pathway. The SNHG5–GNB2 axis orchestrates a multilayered regulatory network that integrates EMT induction, immune suppression, and metabolic adaptation, highlighting its potential as a mechanistic driver and therapeutic target in metastatic CRC.</div></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"17 ","pages":"Pages 128-149"},"PeriodicalIF":4.7,"publicationDate":"2026-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145884388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epigenetic H3K4me3 activation of miR-155-5p promotes intervertebral disc degeneration via autophagy and ageing in nucleus pulposus cells 表观遗传H3K4me3激活miR-155-5p通过髓核细胞的自噬和老化促进椎间盘退变
IF 4.7 3区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-26 DOI: 10.1016/j.ncrna.2025.12.001
Ximeng Wang , Hanqiu Sun , Wenbiao Xiao , Yuxuan Zhang , Xiao Lu , Zhaoyang Gong , Dachuan Li , Siyang Liu , Xinlei Xia , Hongli Wang , Minghao Shao , Guangyu Xu , Xiaosheng Ma
Nucleus pulposus (NP) cell ageing and impaired autophagy - lysosome biogenesis (ALB) are key drivers of intervertebral disc degeneration (IVDD). The upstream epigenetic regulation of transcription factor EB (TFEB), a major ALB regulator, remains elusive. Our study identifies a H3K4me3-associated miRNA pathway that modulates TFEB activity and IVDD progression. Using in vivo and in vitro models, we found that methyltransferase MLL3 knockdown reduces H3K4me3 methylation at the miR-155-5p promoter, suppressing miR-155-5p transcription. MiR-155-5p directly targets FBXO22, indirectly repressing TFEB transcription and exacerbating NP cells ageing and IVDD. Notably, experiments confirmed MLL3 binds specifically to the miR-155-5p promoter, with no interaction detected at the TFEB or FBXO22 promoters. Our data establish a linear H3K4me3/miR-155-5p/FBXO22/TFEB axis in IVDD pathogenesis. We reveal a novel epigenetic crosstalk where H3K4me3 methylation mediates miRNA-driven TFEB regulation, independent of canonical mTOR signaling. These findings enhance understanding of epigenetic mechanisms in autophagy and ageing control and highlight MLL3 and miR-155-5p as potential IVDD therapeutic targets.
髓核(NP)细胞老化和自噬-溶酶体生物发生受损(ALB)是椎间盘退变(IVDD)的关键驱动因素。转录因子EB (TFEB)是ALB的主要调控因子,其上游表观遗传调控尚不明确。我们的研究确定了一个h3k4me3相关的miRNA通路,该通路调节TFEB活性和IVDD进展。通过体内和体外模型,我们发现甲基转移酶MLL3敲低降低了miR-155-5p启动子处的H3K4me3甲基化,抑制了miR-155-5p的转录。MiR-155-5p直接靶向FBXO22,间接抑制TFEB转录,加剧NP细胞老化和IVDD。值得注意的是,实验证实MLL3特异性结合miR-155-5p启动子,而在TFEB或FBXO22启动子上未检测到相互作用。我们的数据在IVDD发病机制中建立了H3K4me3/miR-155-5p/FBXO22/TFEB线性轴。我们揭示了一种新的表观遗传串扰,其中H3K4me3甲基化介导mirna驱动的TFEB调控,独立于典型的mTOR信号传导。这些发现增强了对自噬和衰老控制的表观遗传机制的理解,并强调了MLL3和miR-155-5p是潜在的IVDD治疗靶点。
{"title":"Epigenetic H3K4me3 activation of miR-155-5p promotes intervertebral disc degeneration via autophagy and ageing in nucleus pulposus cells","authors":"Ximeng Wang ,&nbsp;Hanqiu Sun ,&nbsp;Wenbiao Xiao ,&nbsp;Yuxuan Zhang ,&nbsp;Xiao Lu ,&nbsp;Zhaoyang Gong ,&nbsp;Dachuan Li ,&nbsp;Siyang Liu ,&nbsp;Xinlei Xia ,&nbsp;Hongli Wang ,&nbsp;Minghao Shao ,&nbsp;Guangyu Xu ,&nbsp;Xiaosheng Ma","doi":"10.1016/j.ncrna.2025.12.001","DOIUrl":"10.1016/j.ncrna.2025.12.001","url":null,"abstract":"<div><div>Nucleus pulposus (NP) cell ageing and impaired autophagy - lysosome biogenesis (ALB) are key drivers of intervertebral disc degeneration (IVDD). The upstream epigenetic regulation of transcription factor EB (TFEB), a major ALB regulator, remains elusive. Our study identifies a H3K4me3-associated miRNA pathway that modulates TFEB activity and IVDD progression. Using <em>in vivo</em> and <em>in vitro</em> models, we found that methyltransferase MLL3 knockdown reduces H3K4me3 methylation at the miR-155-5p promoter, suppressing miR-155-5p transcription. MiR-155-5p directly targets FBXO22, indirectly repressing TFEB transcription and exacerbating NP cells ageing and IVDD. Notably, experiments confirmed MLL3 binds specifically to the miR-155-5p promoter, with no interaction detected at the TFEB or FBXO22 promoters. Our data establish a linear H3K4me3/miR-155-5p/FBXO22/TFEB axis in IVDD pathogenesis. We reveal a novel epigenetic crosstalk where H3K4me3 methylation mediates miRNA-driven TFEB regulation, independent of canonical mTOR signaling. These findings enhance understanding of epigenetic mechanisms in autophagy and ageing control and highlight MLL3 and miR-155-5p as potential IVDD therapeutic targets.</div></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"17 ","pages":"Pages 112-127"},"PeriodicalIF":4.7,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145840625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The crosstalk network of non-coding RNAs: Emerging opportunities for the clinical application of osteoporosis 非编码rna的串扰网络:骨质疏松症临床应用的新机遇
IF 4.7 3区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-17 DOI: 10.1016/j.ncrna.2025.11.008
Chunlu Yan , Qiao Wan , Zeling Fang , Chuangwei Sui , Xiaolong Xiao , Fan Yang , Baoshan Di , Yajun Li , Juan Yu , Yana Zhao , Guoliang Liu , Yibo Zhou , Wei Li , Fangyu An
Current methods for testing bone density lack the capability to detect patients with early bone loss, and existing osteoporosis therapies have limitations in their efficacy and safety. Therefore, the development of more precise and convenient diagnostic technologies and novel treatments is of paramount importance. Extracellular vesicle (EV)-mediated non-coding RNA (ncRNA) interaction networks enable both the detection of early bone loss and targeted therapy for enhanced treatment outcomes. In this review, we highlight the utility of EVs for carrying various ncRNAs (e.g., miRNAs, lncRNAs, and circRNAs) and thereby forming a complex regulatory network amongst bone-related cells such as osteoblasts and osteoclasts. The mechanisms through which EVs regulate bone cells and their potential for clinical translation are described in detail. Although the EV-mediated ncRNA network holds great promise for the precise diagnosis and targeted treatment of osteoporosis, rigorous large-scale studies are still required to address challenges related to its specificity and clinical application.
目前检测骨密度的方法缺乏检测早期骨质流失患者的能力,并且现有的骨质疏松治疗方法在其有效性和安全性方面存在局限性。因此,开发更精确和方便的诊断技术和新的治疗方法至关重要。细胞外囊泡(EV)介导的非编码RNA (ncRNA)相互作用网络能够检测早期骨质流失和靶向治疗,从而提高治疗效果。在这篇综述中,我们强调了ev携带各种ncrna(例如,mirna, lncrna和circrna)的作用,从而在骨相关细胞(如成骨细胞和破骨细胞)之间形成复杂的调控网络。通过ev调节骨细胞的机制及其潜在的临床翻译进行了详细的描述。尽管ev介导的ncRNA网络在骨质疏松症的精确诊断和靶向治疗方面具有很大的前景,但仍需要严格的大规模研究来解决其特异性和临床应用方面的挑战。
{"title":"The crosstalk network of non-coding RNAs: Emerging opportunities for the clinical application of osteoporosis","authors":"Chunlu Yan ,&nbsp;Qiao Wan ,&nbsp;Zeling Fang ,&nbsp;Chuangwei Sui ,&nbsp;Xiaolong Xiao ,&nbsp;Fan Yang ,&nbsp;Baoshan Di ,&nbsp;Yajun Li ,&nbsp;Juan Yu ,&nbsp;Yana Zhao ,&nbsp;Guoliang Liu ,&nbsp;Yibo Zhou ,&nbsp;Wei Li ,&nbsp;Fangyu An","doi":"10.1016/j.ncrna.2025.11.008","DOIUrl":"10.1016/j.ncrna.2025.11.008","url":null,"abstract":"<div><div>Current methods for testing bone density lack the capability to detect patients with early bone loss, and existing osteoporosis therapies have limitations in their efficacy and safety. Therefore, the development of more precise and convenient diagnostic technologies and novel treatments is of paramount importance. Extracellular vesicle (EV)-mediated non-coding RNA (ncRNA) interaction networks enable both the detection of early bone loss and targeted therapy for enhanced treatment outcomes. In this review, we highlight the utility of EVs for carrying various ncRNAs (e.g., miRNAs, lncRNAs, and circRNAs) and thereby forming a complex regulatory network amongst bone-related cells such as osteoblasts and osteoclasts. The mechanisms through which EVs regulate bone cells and their potential for clinical translation are described in detail. Although the EV-mediated ncRNA network holds great promise for the precise diagnosis and targeted treatment of osteoporosis, rigorous large-scale studies are still required to address challenges related to its specificity and clinical application.</div></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"17 ","pages":"Pages 90-111"},"PeriodicalIF":4.7,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hsa_circ_0101645 contributes to excessive autophagy and apoptosis in intervertebral disc degeneration by acting as a miR-1304-5p sponge modulating BNIP3 expression Hsa_circ_0101645通过作为miR-1304-5p海绵调节BNIP3表达,参与椎间盘退变中过度自噬和凋亡
IF 4.7 3区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-16 DOI: 10.1016/j.ncrna.2025.11.007
Jianhai Luo , Tong Yu , Pengcheng Hu , Jie Liu

Background

Intervertebral disc (IVD) degeneration (IVDD) is the pathological foundation and principal cause for degenerative spine related diseases. Currently, its molecular pathogenesis and reliable biomarkers remain poorly understood. This study intends to elucidate the potential molecular mechanisms of circular RNAs (circRNAs) in IVDD, and to identify novel targeted therapeutic strategies.

Methods

Differentially expressed circRNAs (DE-circRNAs) were obtained by a secondary analysis of the IVDD-related dataset GSE67566, followed by enrichment analysis of their host genes. Both in vitro mechanical loading-induced and in vivo tail suspension-induced models were applied to validate the functions of hsa_circ_0101645, miRNA-1304-05p, and BCL2 Interacting Protein 3 (BNIP3) in IVDD. The competing endogenous RNA (ceRNA) mechanism involving hsa_circ_0101645/miR-1304-5p/BNIP3 was authenticated using dual luciferase reporter genes, Argonaute2-RNA binding protein immunoprecipitation, and RNA-RNA pull down.

Results

In the bioinformatics, there were 354 significantly down-regulated and 282 up-regulated DE-circRNAs in IVDD. The host genes of these circRNAs were mainly enriched in cell morphogenesis, autophagy, and apoptosis. In clinical samples, hsa_circ_0101645 in DE-circRNAs was markedly overexpressed in endplate chondrocytes (EPC) derived from IVDD patients and was predominantly localized in the cytoplasm. In vitro, overexpression of hsa_circ_0101645 and BNIP3, or knockdown of miR-1304-5p, dramatically diminished EPC viability and enlarged apoptosis and autophagic flux. In vivo, sa_circ_0101645 knockdown alleviated structural collapse and tissue lesions in the cartilage endplates, nucleus pulposus and annulus fibrosus of the IVD. Mechanistically, Hsa_circ_0101645 upregulated BNIP3 expression by serving as miR-1304-5p sponge.

Conclusions

Hsa_circ_0101645 service as ceRNA that facilitates IVDD process by mediating proliferation, apoptosis, and excessive autophagy of CEP via the miR-1304-5p/BNIP3 axis. These findings suggest that hsa_circ_0101645 represents a promising molecular target for IVDD therapy.
背景椎间盘退变是脊柱退行性疾病的病理基础和主要原因。目前,其分子发病机制和可靠的生物标志物仍知之甚少。本研究旨在阐明环状rna (circRNAs)在IVDD中的潜在分子机制,并确定新的靶向治疗策略。方法通过对ivdd相关数据集GSE67566进行二次分析获得差异表达的环状rna (DE-circRNAs),然后对其宿主基因进行富集分析。采用体外机械负荷诱导和体内尾悬浮诱导模型验证hsa_circ_0101645、miRNA-1304-05p和BCL2相互作用蛋白3 (BCL2 Interacting Protein 3, BNIP3)在IVDD中的功能。通过双荧光素酶报告基因、Argonaute2-RNA结合蛋白免疫沉淀和RNA-RNA拉下验证了涉及hsa_circ_0101645/miR-1304-5p/BNIP3的竞争内源性RNA (ceRNA)机制。结果在生物信息学方面,在IVDD中有354个de - circrna显著下调,282个de - circrna显著上调。这些环状rna的宿主基因主要富集于细胞形态发生、自噬和凋亡。在临床样本中,DE-circRNAs中的hsa_circ_0101645在来自IVDD患者的终板软骨细胞(EPC)中显著过表达,并且主要定位于细胞质中。在体外,过表达hsa_circ_0101645和BNIP3,或敲低miR-1304-5p,显著降低EPC活力,增加凋亡和自噬通量。在体内,sa_circ_0101645敲低减轻了IVD软骨终板、髓核和纤维环的结构塌陷和组织病变。机制上,Hsa_circ_0101645通过充当miR-1304-5p海绵上调BNIP3的表达。结论shsa_circ_0101645通过miR-1304-5p/BNIP3轴介导CEP的增殖、凋亡和过度自噬,作为促进IVDD过程的ceRNA。这些发现表明hsa_circ_0101645代表了IVDD治疗的一个有希望的分子靶点。
{"title":"Hsa_circ_0101645 contributes to excessive autophagy and apoptosis in intervertebral disc degeneration by acting as a miR-1304-5p sponge modulating BNIP3 expression","authors":"Jianhai Luo ,&nbsp;Tong Yu ,&nbsp;Pengcheng Hu ,&nbsp;Jie Liu","doi":"10.1016/j.ncrna.2025.11.007","DOIUrl":"10.1016/j.ncrna.2025.11.007","url":null,"abstract":"<div><h3>Background</h3><div>Intervertebral disc (IVD) degeneration (IVDD) is the pathological foundation and principal cause for degenerative spine related diseases. Currently, its molecular pathogenesis and reliable biomarkers remain poorly understood. This study intends to elucidate the potential molecular mechanisms of circular RNAs (circRNAs) in IVDD, and to identify novel targeted therapeutic strategies.</div></div><div><h3>Methods</h3><div>Differentially expressed circRNAs (DE-circRNAs) were obtained by a secondary analysis of the IVDD-related dataset GSE67566, followed by enrichment analysis of their host genes. Both <em>in vitro</em> mechanical loading-induced and <em>in vivo</em> tail suspension-induced models were applied to validate the functions of hsa_circ_0101645, miRNA-1304-05p, and BCL2 Interacting Protein 3 (BNIP3) in IVDD. The competing endogenous RNA (ceRNA) mechanism involving hsa_circ_0101645/miR-1304-5p/BNIP3 was authenticated using dual luciferase reporter genes, Argonaute2-RNA binding protein immunoprecipitation, and RNA-RNA pull down.</div></div><div><h3>Results</h3><div>In the bioinformatics, there were 354 significantly down-regulated and 282 up-regulated DE-circRNAs in IVDD. The host genes of these circRNAs were mainly enriched in cell morphogenesis, autophagy, and apoptosis. In clinical samples, hsa_circ_0101645 in DE-circRNAs was markedly overexpressed in endplate chondrocytes (EPC) derived from IVDD patients and was predominantly localized in the cytoplasm. <em>In vitro</em>, overexpression of hsa_circ_0101645 and BNIP3, or knockdown of miR-1304-5p, dramatically diminished EPC viability and enlarged apoptosis and autophagic flux. <em>In vivo</em>, sa_circ_0101645 knockdown alleviated structural collapse and tissue lesions in the cartilage endplates, nucleus pulposus and annulus fibrosus of the IVD. Mechanistically, Hsa_circ_0101645 upregulated BNIP3 expression by serving as miR-1304-5p sponge.</div></div><div><h3>Conclusions</h3><div>Hsa_circ_0101645 service as ceRNA that facilitates IVDD process by mediating proliferation, apoptosis, and excessive autophagy of CEP via the miR-1304-5p/BNIP3 axis. These findings suggest that hsa_circ_0101645 represents a promising molecular target for IVDD therapy.</div></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"17 ","pages":"Pages 76-89"},"PeriodicalIF":4.7,"publicationDate":"2025-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
circ_0103896/miR-432–5p/FTO feedback loop suppresses the formation and progression of intracranial aneurysm circ_0103896/ miR-432-5p /FTO反馈回路抑制颅内动脉瘤的形成和发展
IF 4.7 3区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-15 DOI: 10.1016/j.ncrna.2025.11.001
Zhiwen Lu , Shijie Zhu , Yina Wu , Fengfeng Xu , Qinghai Huang
Circular RNAs (circRNAs) and m6A RNA methylation play crucial roles in the pathogenesis of intracranial aneurysm (IA); however, their regulatory interplay remains unclear. Through circRNA profiling of 16 IA tissues and 8 superficial temporal arteries, we identified hsa_circ_0103896 as significantly downregulated in IA. RT-qPCR analysis further revealed that decreased circ_0103896 or increased miR-432–5p expression correlated with IA progression. Functional assays demonstrated that circ_0103896 inhibited the phenotypic switch of human brain vascular smooth muscle cells (hBVSMCs) from a contractile to a synthetic state, whereas circ_0103896 knockdown reversed this effect. In vivo, circ_0103896 overexpression alleviated IA severity, whereas its depletion aggravated aneurysm formation. Mechanistically, circ_0103896 functioned as a sponge for miR-432–5p, thereby upregulating FTO, which in turn promoted m6A demethylation of circ_0103896. This process reinforced circ_0103896 expression, forming a positive feedback loop. The circ_0103896/miR-432–5p/FTO axis thus suppresses hBVSMC phenotypic transformation and mitigates IA progression. These findings reveal a novel epigenetic mechanism involving m6A modification and circRNA–miRNA crosstalk in IA pathogenesis, highlighting circ_0103896 as a potential therapeutic target.
环状RNA (circRNAs)和m6A RNA甲基化在颅内动脉瘤(IA)的发病机制中发挥关键作用;然而,它们在监管方面的相互作用仍不清楚。通过16个IA组织和8个颞浅动脉的circRNA分析,我们发现hsa_circ_0103896在IA中显著下调。RT-qPCR分析进一步显示circ_0103896表达降低或miR-432-5p表达升高与IA进展相关。功能分析表明,circ_0103896抑制了人脑血管平滑肌细胞(hBVSMCs)从收缩状态到合成状态的表型转换,而circ_0103896敲低则逆转了这一作用。在体内,circ_0103896过表达减轻了IA的严重程度,而其缺失则加重了动脉瘤的形成。在机制上,circ_0103896作为miR-432-5p的海绵,从而上调FTO,进而促进circ_0103896的m6A去甲基化。这个过程强化了circ_0103896表达,形成了一个正反馈循环。circ_0103896/ miR-432-5p /FTO轴因此抑制hBVSMC表型转化并减轻IA进展。这些发现揭示了IA发病机制中涉及m6A修饰和circRNA-miRNA串扰的一种新的表观遗传机制,强调circ_0103896是潜在的治疗靶点。
{"title":"circ_0103896/miR-432–5p/FTO feedback loop suppresses the formation and progression of intracranial aneurysm","authors":"Zhiwen Lu ,&nbsp;Shijie Zhu ,&nbsp;Yina Wu ,&nbsp;Fengfeng Xu ,&nbsp;Qinghai Huang","doi":"10.1016/j.ncrna.2025.11.001","DOIUrl":"10.1016/j.ncrna.2025.11.001","url":null,"abstract":"<div><div>Circular RNAs (circRNAs) and m<sup>6</sup>A RNA methylation play crucial roles in the pathogenesis of intracranial aneurysm (IA); however, their regulatory interplay remains unclear. Through circRNA profiling of 16 IA tissues and 8 superficial temporal arteries, we identified hsa_circ_0103896 as significantly downregulated in IA. RT-qPCR analysis further revealed that decreased circ_0103896 or increased miR-432–5p expression correlated with IA progression. Functional assays demonstrated that circ_0103896 inhibited the phenotypic switch of human brain vascular smooth muscle cells (hBVSMCs) from a contractile to a synthetic state, whereas circ_0103896 knockdown reversed this effect. <em>In vivo</em>, circ_0103896 overexpression alleviated IA severity, whereas its depletion aggravated aneurysm formation. Mechanistically, circ_0103896 functioned as a sponge for miR-432–5p, thereby upregulating FTO, which in turn promoted m<sup>6</sup>A demethylation of circ_0103896. This process reinforced circ_0103896 expression, forming a positive feedback loop. The circ_0103896/miR-432–5p/FTO axis thus suppresses hBVSMC phenotypic transformation and mitigates IA progression. These findings reveal a novel epigenetic mechanism involving m<sup>6</sup>A modification and circRNA–miRNA crosstalk in IA pathogenesis, highlighting circ_0103896 as a potential therapeutic target.</div></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"17 ","pages":"Pages 59-75"},"PeriodicalIF":4.7,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145797816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
LncRNA ZFAS1 in hepatocellular carcinoma: A systematic review of molecular mechanisms and clinical translation LncRNA ZFAS1在肝细胞癌中的分子机制和临床翻译的系统综述
IF 4.7 3区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-05 DOI: 10.1016/j.ncrna.2025.11.003
Peng Zhu , Hui-ying Liu
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality globally, with its high recurrence rate and therapeutic resistance underscoring the urgent need for breakthrough molecular targets. The long non-coding RNA ZFAS1 has emerged as a critical regulatory hub in HCC pathogenesis through its multidimensional mechanisms. Clinical investigations reveal significant ZFAS1 overexpression in HCC tissues, which is strongly associated with microvascular invasion, lymph node metastasis, and unfavorable clinical outcomes. Meta-analytical data further corroborate its independent prognostic value in survival prediction.
Mechanistically, ZFAS1 functions as a competitive endogenous RNA (ceRNA) that sequesters tumor-suppressive miRNAs including miR-150 and miR-193a-3p, thereby de-repressing downstream oncogenic targets such as ZEB1/MMP14 and RALY/HGF/c-Met. This molecular interplay drives epithelial-mesenchymal transition (EMT) and metastatic progression, while ZFAS1-encoded micropeptides concurrently inhibit ferroptosis through mitochondrial ROS modulation and the miR-150/AIFM2 axis, thereby synergistically enhancing tumor proliferation and apoptotic resistance. Within the tumor microenvironment (TME), exosome-derived ZFAS1 remodels intercellular communication networks, promoting angiogenesis via STAT3/VEGFA signaling, though its immunometabolic regulatory mechanisms warrant further elucidation. Clinically, plasma ZFAS1 demonstrates enhanced diagnostic utility when combined with alpha-fetoprotein (AUC = 0.891), while therapeutic targeting of ZFAS1-mediated PI3K-AKT and PERK/ATF4 pathways shows promise in overcoming sorafenib/donafenib resistance. Current translational challenges include ZFAS1 isoform heterogeneity, suboptimal liquid biopsy sensitivity, and dynamic TME interactions.
Future directions should employ multi-omics integration (spatial transcriptomics/single-cell sequencing) coupled with AI-driven network modeling to systematically decode ZFAS1's regulatory architecture, ultimately enabling precision theranostic strategies for HCC management.
肝细胞癌(HCC)仍然是全球癌症相关死亡的主要原因,其高复发率和治疗耐药性强调了迫切需要突破性的分子靶点。长链非编码RNA ZFAS1通过其多维机制成为HCC发病机制的关键调控枢纽。临床研究显示ZFAS1在HCC组织中显著过表达,与微血管侵袭、淋巴结转移及不良临床预后密切相关。meta分析数据进一步证实了其在生存预测中的独立预后价值。在机制上,ZFAS1作为竞争性内源性RNA (ceRNA),隔离肿瘤抑制mirna,包括miR-150和miR-193a-3p,从而去抑制下游致癌靶标,如ZEB1/MMP14和RALY/HGF/c-Met。这种分子间相互作用驱动上皮-间质转化(EMT)和转移进展,而zfas1编码的微肽通过线粒体ROS调节和miR-150/AIFM2轴同时抑制铁凋亡,从而协同增强肿瘤增殖和凋亡抵抗。在肿瘤微环境(TME)中,外泌体衍生的ZFAS1重塑细胞间通讯网络,通过STAT3/VEGFA信号通路促进血管生成,尽管其免疫代谢调节机制有待进一步阐明。临床上,血浆ZFAS1联合甲胎蛋白(AUC = 0.891)显示出增强的诊断效用,而治疗靶向ZFAS1介导的PI3K-AKT和PERK/ATF4通路显示出克服索拉非尼/多纳非尼耐药的希望。目前的翻译挑战包括ZFAS1异构体异质性、次优液体活检敏感性和动态TME相互作用。未来的方向应该采用多组学整合(空间转录组学/单细胞测序),结合人工智能驱动的网络建模,系统地解码ZFAS1的调控结构,最终实现HCC管理的精确治疗策略。
{"title":"LncRNA ZFAS1 in hepatocellular carcinoma: A systematic review of molecular mechanisms and clinical translation","authors":"Peng Zhu ,&nbsp;Hui-ying Liu","doi":"10.1016/j.ncrna.2025.11.003","DOIUrl":"10.1016/j.ncrna.2025.11.003","url":null,"abstract":"<div><div>Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality globally, with its high recurrence rate and therapeutic resistance underscoring the urgent need for breakthrough molecular targets. The long non-coding RNA ZFAS1 has emerged as a critical regulatory hub in HCC pathogenesis through its multidimensional mechanisms. Clinical investigations reveal significant ZFAS1 overexpression in HCC tissues, which is strongly associated with microvascular invasion, lymph node metastasis, and unfavorable clinical outcomes. Meta-analytical data further corroborate its independent prognostic value in survival prediction.</div><div>Mechanistically, ZFAS1 functions as a competitive endogenous RNA (ceRNA) that sequesters tumor-suppressive miRNAs including miR-150 and miR-193a-3p, thereby de-repressing downstream oncogenic targets such as ZEB1/MMP14 and RALY/HGF/c-Met. This molecular interplay drives epithelial-mesenchymal transition (EMT) and metastatic progression, while ZFAS1-encoded micropeptides concurrently inhibit ferroptosis through mitochondrial ROS modulation and the miR-150/AIFM2 axis, thereby synergistically enhancing tumor proliferation and apoptotic resistance. Within the tumor microenvironment (TME), exosome-derived ZFAS1 remodels intercellular communication networks, promoting angiogenesis via STAT3/VEGFA signaling, though its immunometabolic regulatory mechanisms warrant further elucidation. Clinically, plasma ZFAS1 demonstrates enhanced diagnostic utility when combined with alpha-fetoprotein (AUC = 0.891), while therapeutic targeting of ZFAS1-mediated PI3K-AKT and PERK/ATF4 pathways shows promise in overcoming sorafenib/donafenib resistance. Current translational challenges include ZFAS1 isoform heterogeneity, suboptimal liquid biopsy sensitivity, and dynamic TME interactions.</div><div>Future directions should employ multi-omics integration (spatial transcriptomics/single-cell sequencing) coupled with AI-driven network modeling to systematically decode ZFAS1's regulatory architecture, ultimately enabling precision theranostic strategies for HCC management.</div></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"17 ","pages":"Pages 44-53"},"PeriodicalIF":4.7,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145692651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TPR is required for circRNA, lncRNA and mRNA nuclear export TPR是circRNA、lncRNA和mRNA核输出所必需的
IF 4.7 3区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-05 DOI: 10.1016/j.ncrna.2025.11.010
Min Zhou , Ruirui Jia , Mengya Gao , Jun Yang , Hongbo Qi

Background

Efficient RNA nuclear export is essential for proper cellular function and normal physiology, with defects in this process leading to pathological consequences. Our study aimed to investigate the role of translocated promoter region (TPR), nuclear basket protein, in orchestrating RNA transport in human cells as well as the function of TPR-mediated RNA nuclear export in cervical cancer cells.

Methods

RNA sequencing and bioinformatic analysis were applied to explore the effect of TPR on circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), and mRNAs nuclear export and their corresponding sequence characteristic. Fluorescence in situ hybridization was employed to explore the role of TPR in RNA nuclear export. Immunofluorescence staining was used to study the role of TPR in R-loop and DNA damage. Flow cytometry assay was applied to investigate the influence of TPR on cell cycle in cervical cancer cells.

Results

TPR depletion leads to the nuclear accumulation of 7243 circRNAs, 1913 lncRNAs, and 2758 mRNAs. Codepletion and rescue experiments suggested that the modulation of TPR-mediated circRNAs nuclear export might be independent of XPO4. The regulation of TPR-mediated circRNAs nuclear export is independent of circRNAs characteristics, while, the regulation of TPR-mediated lncRNAs and mRNAs nuclear export is partly dependent on lncRNAs/mRNAs transcription length. Moreover, the lack of TPR results in nuclear R-loop accumulation, causing DNA damage and cell cycle arrest as well as subsequent inhibition of cell proliferation in cervical cancer cells.

Conclusions

This study highlights the nuclear export of circRNA, lncRNA and mRNA relies critically on TPR, a mechanism that may inhibit nuclear accumulation of R-loop and DNA damage in cervical cancer cells.
RNA核输出不足对正常的细胞功能和生理机能至关重要,这一过程中的缺陷会导致病理后果。本研究旨在探讨核筐蛋白易位启动子区(TPR)在人细胞RNA转运中的作用,以及TPR介导的RNA核输出在宫颈癌细胞中的功能。方法采用srna测序和生物信息学分析方法,探讨TPR对环状rna (circRNAs)、长链非编码rna (lncRNAs)和mrna核输出的影响及其相应的序列特征。采用荧光原位杂交技术探讨TPR在RNA核输出中的作用。免疫荧光染色法研究TPR在R-loop和DNA损伤中的作用。采用流式细胞术研究TPR对宫颈癌细胞周期的影响。结果stpr缺失导致7243个circrna、1913个lncrna和2758个mrna的核积累。Codepletion和rescue实验表明,tpr介导的circRNAs核输出的调节可能独立于XPO4。tpr介导的circRNAs核输出调控与circRNAs的特性无关,而tpr介导的lncRNAs和mrna核输出调控部分依赖于lncRNAs/ mrna的转录长度。此外,缺乏TPR会导致核r环积累,导致宫颈癌细胞DNA损伤和细胞周期阻滞,进而抑制细胞增殖。结论本研究强调circRNA、lncRNA和mRNA的核输出严重依赖于TPR,这一机制可能抑制宫颈癌细胞中R-loop的核积累和DNA损伤。
{"title":"TPR is required for circRNA, lncRNA and mRNA nuclear export","authors":"Min Zhou ,&nbsp;Ruirui Jia ,&nbsp;Mengya Gao ,&nbsp;Jun Yang ,&nbsp;Hongbo Qi","doi":"10.1016/j.ncrna.2025.11.010","DOIUrl":"10.1016/j.ncrna.2025.11.010","url":null,"abstract":"<div><h3>Background</h3><div>Efficient RNA nuclear export is essential for proper cellular function and normal physiology, with defects in this process leading to pathological consequences. Our study aimed to investigate the role of translocated promoter region (TPR), nuclear basket protein, in orchestrating RNA transport in human cells as well as the function of TPR-mediated RNA nuclear export in cervical cancer cells.</div></div><div><h3>Methods</h3><div>RNA sequencing and bioinformatic analysis were applied to explore the effect of TPR on circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), and mRNAs nuclear export and their corresponding sequence characteristic. Fluorescence in situ hybridization was employed to explore the role of TPR in RNA nuclear export. Immunofluorescence staining was used to study the role of TPR in R-loop and DNA damage. Flow cytometry assay was applied to investigate the influence of TPR on cell cycle in cervical cancer cells.</div></div><div><h3>Results</h3><div>TPR depletion leads to the nuclear accumulation of 7243 circRNAs, 1913 lncRNAs, and 2758 mRNAs. Codepletion and rescue experiments suggested that the modulation of TPR-mediated circRNAs nuclear export might be independent of XPO4. The regulation of TPR-mediated circRNAs nuclear export is independent of circRNAs characteristics, while, the regulation of TPR-mediated lncRNAs and mRNAs nuclear export is partly dependent on lncRNAs/mRNAs transcription length. Moreover, the lack of TPR results in nuclear R-loop accumulation, causing DNA damage and cell cycle arrest as well as subsequent inhibition of cell proliferation in cervical cancer cells.</div></div><div><h3>Conclusions</h3><div>This study highlights the nuclear export of circRNA, lncRNA and mRNA relies critically on TPR, a mechanism that may inhibit nuclear accumulation of R-loop and DNA damage in cervical cancer cells.</div></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"17 ","pages":"Pages 32-43"},"PeriodicalIF":4.7,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145692652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The regulatory role of circGDI2 in hepatocellular carcinoma proliferation and glycolysis with the involvement of m6A modification circGDI2在肝细胞癌增殖和糖酵解中的调节作用与m6A修饰的参与
IF 4.7 3区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-04 DOI: 10.1016/j.ncrna.2025.11.006
Shiyi Chen , Hongxiang Xia , Shuwei Chen

Background

Hepatocellular carcinoma (HCC) is a highly aggressive malignancy, and metabolic reprogramming, particularly glycolysis, plays a crucial role in its progression. Circular RNAs (circRNAs) and N6-methyladenosine (m6A) modifications have emerged as key regulators in HCC, but the role of circGDI2 and its underlying mechanisms remain unclear.

Objective

This study aimed to investigate the functional role and mechanism of circGDI2 in HCC proliferation and glycolysis.

Methods

The expression of circGDI2 was detected by RT-qPCR. RNase R treatment was used to verify the stability of circGDI2. Functional assays, including CCK-8, glycolysis analysis (glucose consumption, lactate production), and xenograft model, were performed to assess proliferation and glycolysis. Bioinformatics prediction, MeRIP, and luciferase reporter assays were used to explore the interaction between circGDI2, IGF2BP2, and PKM2.

Results

CircGDI2 was highly expressed in HCC tissues and cells, and exhibited cytoplasm localization. Silencing circGDI2 inhibited Li-7 and Huh-7 cell proliferation and glycolysis, downregulated PKM2, and suppressed tumor growth. Mechanistically, circGDI2 regulated PKM2 through the m6A “reader” IGF2BP2, and its overexpression partially rescued the inhibitory effects of circGDI2 knockdown. Furthermore, FTO-mediated m6A modification enhanced circGDI2 stability and expression. Silencing FTO inhibited HCC cell proliferation, glycolysis, and tumor growth, and decreased the levels of circGDI2, IGF2BP2, and PKM2.

Conclusions

FTO-mediated m6A modification of circGDI2 promotes HCC proliferation and glycolysis via the IGF2BP2/PKM2 axis, suggesting circGDI2 as a potential therapeutic target for HCC.
肝细胞癌(HCC)是一种高度侵袭性的恶性肿瘤,代谢重编程,特别是糖酵解,在其进展中起着至关重要的作用。环状rna (circRNAs)和n6 -甲基腺苷(m6A)修饰已成为HCC的关键调节因子,但circGDI2的作用及其潜在机制尚不清楚。目的探讨circGDI2在肝癌细胞增殖和糖酵解中的功能作用及机制。方法采用RT-qPCR检测circGDI2的表达。采用RNase R处理验证circGDI2的稳定性。功能分析,包括CCK-8,糖酵解分析(葡萄糖消耗,乳酸生成)和异种移植物模型,用于评估增殖和糖酵解。使用生物信息学预测、MeRIP和荧光素酶报告基因检测来探索circGDI2、IGF2BP2和PKM2之间的相互作用。结果scircgdi2在HCC组织和细胞中高表达,并表现出细胞质定位。沉默circGDI2抑制Li-7和Huh-7细胞增殖和糖酵解,下调PKM2,抑制肿瘤生长。从机制上讲,circGDI2通过m6A“读取器”IGF2BP2调控PKM2,其过表达部分挽救了circGDI2敲低的抑制作用。此外,fto介导的m6A修饰增强了circGDI2的稳定性和表达。沉默FTO抑制HCC细胞增殖、糖酵解和肿瘤生长,并降低circGDI2、IGF2BP2和PKM2的水平。结论sfto介导的m6A修饰circGDI2通过IGF2BP2/PKM2轴促进HCC增殖和糖酵解,提示circGDI2可能是HCC的潜在治疗靶点。
{"title":"The regulatory role of circGDI2 in hepatocellular carcinoma proliferation and glycolysis with the involvement of m6A modification","authors":"Shiyi Chen ,&nbsp;Hongxiang Xia ,&nbsp;Shuwei Chen","doi":"10.1016/j.ncrna.2025.11.006","DOIUrl":"10.1016/j.ncrna.2025.11.006","url":null,"abstract":"<div><h3>Background</h3><div>Hepatocellular carcinoma (HCC) is a highly aggressive malignancy, and metabolic reprogramming, particularly glycolysis, plays a crucial role in its progression. Circular RNAs (circRNAs) and N6-methyladenosine (m<sup>6</sup>A) modifications have emerged as key regulators in HCC, but the role of circGDI2 and its underlying mechanisms remain unclear.</div></div><div><h3>Objective</h3><div>This study aimed to investigate the functional role and mechanism of circGDI2 in HCC proliferation and glycolysis.</div></div><div><h3>Methods</h3><div>The expression of circGDI2 was detected by RT-qPCR. RNase R treatment was used to verify the stability of circGDI2. Functional assays, including CCK-8, glycolysis analysis (glucose consumption, lactate production), and xenograft model, were performed to assess proliferation and glycolysis. Bioinformatics prediction, MeRIP, and luciferase reporter assays were used to explore the interaction between circGDI2, IGF2BP2, and PKM2.</div></div><div><h3>Results</h3><div>CircGDI2 was highly expressed in HCC tissues and cells, and exhibited cytoplasm localization. Silencing circGDI2 inhibited Li-7 and Huh-7 cell proliferation and glycolysis, downregulated PKM2, and suppressed tumor growth. Mechanistically, circGDI2 regulated PKM2 through the m<sup>6</sup>A “reader” IGF2BP2, and its overexpression partially rescued the inhibitory effects of circGDI2 knockdown. Furthermore, FTO-mediated m<sup>6</sup>A modification enhanced circGDI2 stability and expression. Silencing FTO inhibited HCC cell proliferation, glycolysis, and tumor growth, and decreased the levels of circGDI2, IGF2BP2, and PKM2.</div></div><div><h3>Conclusions</h3><div>FTO-mediated m<sup>6</sup>A modification of circGDI2 promotes HCC proliferation and glycolysis via the IGF2BP2/PKM2 axis, suggesting circGDI2 as a potential therapeutic target for HCC.</div></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"17 ","pages":"Pages 21-31"},"PeriodicalIF":4.7,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145692670","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circular RNA MALAT1 as a potential target for antimetastatic therapy 环状RNA MALAT1作为抗转移治疗的潜在靶点
IF 4.7 3区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-03 DOI: 10.1016/j.ncrna.2025.11.004
Janusz Matuszyk
Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) is a long non-coding RNA (lncRNA) located in the nucleus that is involved in the regulation of gene expression and alternative splicing of gene transcription products. MALAT1 has also been implicated in processes leading to metastasis in various types of cancer. On the other hand, during the epithelial-to-mesenchymal transition (EMT) process of cancer cells, which allows the invasion and migration of cancer cells outside the primary tumor, increases in the levels of the Quaking RNA-binding protein (QKI) were found, which also led to the formation of circular RNA molecules (circRNA), including MALAT1-derived circRNAs. It was also found that at least some MALAT1-derived circRNAs could support processes leading to the spread of cancer cells outside the primary tumor. Due to the unique back-splicing junction in a given circRNA, it is possible to therapeutically target specific circRNA molecules in cancer cells while protecting linear RNAs in normal cells. Without questioning the aberrant involvement of lncRNA MALAT1 in promoting cancer cell migration and invasion, it appears that MALAT1-derived circRNAs, especially the circRNA known as circ-MALAT1 or circ2082 (hsa_circ_0002082), among other circRNAs, may be considered for further study as potential targets for anti-metastatic therapy.
转移相关肺腺癌转录本1 (MALAT1)是一种位于细胞核中的长链非编码RNA (lncRNA),参与基因表达调控和基因转录产物的选择性剪接。MALAT1也参与了导致各种类型癌症转移的过程。另一方面,在癌细胞的上皮-间质转化(EMT)过程中,允许癌细胞在原发肿瘤外侵袭和迁移,发现震动RNA结合蛋白(QKI)水平增加,这也导致环状RNA分子(circRNA)的形成,包括malat1衍生的环状RNA。研究还发现,至少一些malat1衍生的环状rna可以支持导致癌细胞在原发肿瘤外扩散的过程。由于给定circRNA中独特的反向剪接连接,有可能在治疗中靶向癌细胞中的特定circRNA分子,同时保护正常细胞中的线性rna。在不质疑lncRNA MALAT1异常参与促进癌细胞迁移和侵袭的情况下,MALAT1衍生的circRNA,特别是circ-MALAT1或circ2082 (hsa_circ_0002082)等circRNA,可能被认为是抗转移治疗的潜在靶点,值得进一步研究。
{"title":"Circular RNA MALAT1 as a potential target for antimetastatic therapy","authors":"Janusz Matuszyk","doi":"10.1016/j.ncrna.2025.11.004","DOIUrl":"10.1016/j.ncrna.2025.11.004","url":null,"abstract":"<div><div>Metastasis Associated Lung Adenocarcinoma Transcript 1 (MALAT1) is a long non-coding RNA (lncRNA) located in the nucleus that is involved in the regulation of gene expression and alternative splicing of gene transcription products. MALAT1 has also been implicated in processes leading to metastasis in various types of cancer. On the other hand, during the epithelial-to-mesenchymal transition (EMT) process of cancer cells, which allows the invasion and migration of cancer cells outside the primary tumor, increases in the levels of the Quaking RNA-binding protein (QKI) were found, which also led to the formation of circular RNA molecules (circRNA), including <em>MALAT1</em>-derived circRNAs. It was also found that at least some <em>MALAT1</em>-derived circRNAs could support processes leading to the spread of cancer cells outside the primary tumor. Due to the unique back-splicing junction in a given circRNA, it is possible to therapeutically target specific circRNA molecules in cancer cells while protecting linear RNAs in normal cells. Without questioning the aberrant involvement of lncRNA MALAT1 in promoting cancer cell migration and invasion, it appears that <em>MALAT1</em>-derived circRNAs, especially the circRNA known as circ-MALAT1 or circ2082 (hsa_circ_0002082), among other circRNAs, may be considered for further study as potential targets for anti-metastatic therapy.</div></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"17 ","pages":"Pages 12-20"},"PeriodicalIF":4.7,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145692671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The progress of m6A methylation-regulated non-coding RNAs in osteogenic differentiation and osteoporosis m6A甲基化调控非编码rna在成骨分化和骨质疏松中的研究进展
IF 4.7 3区 生物学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-12-02 DOI: 10.1016/j.ncrna.2025.11.005
Yongbin Wang , Baicheng Ma , Jiashuo Qiu , Likun Yu , Jianjun Xiong , Qianfu Yu , Xingnuan Li , Haichun Liao , Youen Huang , Shan He
N6-methyladenosine (m6A) is the most abundant internal modification of eukaryotic RNA, and has increasingly been recognized as a critical regulator of gene expression at both the transcriptional and post-transcriptional levels. The m6A modification process is highly dynamic and reversible, governed by methyltransferase writers (e.g., METTL3, METTL14, WTAP), demethylase erasers (such as FTO and ALKBH5), and specific readers (including YTHDF and IGF2BP protein families) that interpret the modification and mediate its downstream effects. Accumulating evidence indicates that m6A-mediated regulation of non-coding RNAs (ncRNAs) plays a pivotal role in osteogenic differentiation, a process central to bone formation. Impaired osteogenesis, which contributes to decreased bone mass, is closely linked to the onset and progression of osteoporosis. This review summarizes recent progress on the interplay between m6A modification and ncRNAs in osteogenic differentiation, and outlines a regulatory framework, the m6A-ncRNA-target gene axis, that includes m6A modification, ncRNA interactions, and downstream signaling pathways, such as Wnt/β-catenin and BMP/Smad, and discusses their potential as biomarkers or therapeutic targets for osteoporosis, with the goal of providing new insights into the epigenetic mechanisms underlying osteoporosis and to identify potential molecular targets for future therapeutic strategies.
n6 -甲基腺苷(n6 - methylladenosine, m6A)是真核生物RNA中最丰富的内部修饰,在转录和转录后水平上被越来越多地认为是基因表达的关键调控因子。m6A修饰过程是高度动态和可逆的,受甲基转移酶写入器(如METTL3, METTL14, WTAP),去甲基化酶擦除器(如FTO和ALKBH5)和特定读取器(包括YTHDF和IGF2BP蛋白家族)的控制,这些读取器解释修饰并介导其下游效应。越来越多的证据表明,m6a介导的非编码rna (ncRNAs)调控在成骨分化中起着关键作用,成骨分化是骨形成的核心过程。骨质增生受损导致骨量减少,与骨质疏松症的发生和发展密切相关。本文综述了m6A修饰与ncRNA在成骨分化中相互作用的最新进展,概述了m6A-ncRNA靶基因轴的调控框架,包括m6A修饰、ncRNA相互作用和下游信号通路,如Wnt/β-catenin和BMP/Smad,并讨论了它们作为骨质疏松症生物标志物或治疗靶点的潜力。目的是为骨质疏松症的表观遗传机制提供新的见解,并为未来的治疗策略确定潜在的分子靶点。
{"title":"The progress of m6A methylation-regulated non-coding RNAs in osteogenic differentiation and osteoporosis","authors":"Yongbin Wang ,&nbsp;Baicheng Ma ,&nbsp;Jiashuo Qiu ,&nbsp;Likun Yu ,&nbsp;Jianjun Xiong ,&nbsp;Qianfu Yu ,&nbsp;Xingnuan Li ,&nbsp;Haichun Liao ,&nbsp;Youen Huang ,&nbsp;Shan He","doi":"10.1016/j.ncrna.2025.11.005","DOIUrl":"10.1016/j.ncrna.2025.11.005","url":null,"abstract":"<div><div>N6-methyladenosine (m6A) is the most abundant internal modification of eukaryotic RNA, and has increasingly been recognized as a critical regulator of gene expression at both the transcriptional and post-transcriptional levels. The m6A modification process is highly dynamic and reversible, governed by methyltransferase writers (e.g., METTL3, METTL14, WTAP), demethylase erasers (such as FTO and ALKBH5), and specific readers (including YTHDF and IGF2BP protein families) that interpret the modification and mediate its downstream effects. Accumulating evidence indicates that m6A-mediated regulation of non-coding RNAs (ncRNAs) plays a pivotal role in osteogenic differentiation, a process central to bone formation. Impaired osteogenesis, which contributes to decreased bone mass, is closely linked to the onset and progression of osteoporosis. This review summarizes recent progress on the interplay between m6A modification and ncRNAs in osteogenic differentiation, and outlines a regulatory framework, the m6A-ncRNA-target gene axis, that includes m6A modification, ncRNA interactions, and downstream signaling pathways, such as Wnt/β-catenin and BMP/Smad, and discusses their potential as biomarkers or therapeutic targets for osteoporosis, with the goal of providing new insights into the epigenetic mechanisms underlying osteoporosis and to identify potential molecular targets for future therapeutic strategies.</div></div>","PeriodicalId":37653,"journal":{"name":"Non-coding RNA Research","volume":"17 ","pages":"Pages 1-11"},"PeriodicalIF":4.7,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Non-coding RNA Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1